Safety and Efficacy of Atiprimod Treatment for Patients With Low to Intermediate Grade Neuroendocrine Carcinoma

Mount Sinai Medical Center, New York

H. Lee Moffitt Cancer Center & Research Institute, Tampa

Robert H. Lurie Comprehensive Cancer Center of Northwestern, Chicago

Hematology Oncology Services of Arkansas, Little Rock

Scott and White Memorial Hospital, Scott Sherwood and Brindley Facility, Temple

Cedars Sinai Outpatient Cancer Center at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles

Dana Farber Cancer Institute, Boston

Lahey Clinic, Burlington